Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,926 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria.
Li L, Xu X, Wang W, Huang P, Yu L, Ren Z, Fan J, Zhou J, Zhang L, Wang Z. Li L, et al. Among authors: huang p. J Immunother Cancer. 2025 Jan 16;13(1):e010035. doi: 10.1136/jitc-2024-010035. J Immunother Cancer. 2025. PMID: 39824532 Clinical Trial.
Preclinical models of soft tissue sarcomas - generation and applications to enhance translational research.
Pasquali S, Moura DS, Danks MR, Manasterski PJ, Zaffaroni N, Stacchiotti S, Mondaza-Hernandez JL, Kerrison WG, Martin-Broto J, Huang PH, Brunton VG. Pasquali S, et al. Among authors: huang ph. Crit Rev Oncol Hematol. 2025 Jan 15:104621. doi: 10.1016/j.critrevonc.2025.104621. Online ahead of print. Crit Rev Oncol Hematol. 2025. PMID: 39824369 Review.
11,926 results
You have reached the last available page of results. Please see the User Guide for more information.